KCT0007766
Not yet recruiting
未知
Effect of Alternate Treatment with Intravitreal Anti-Vascular Endothelial Growth Factor and Corticosteroid for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion - A randomized prospective open-label controlled trial
Hallym University Medical Center-Kangnam0 sites188 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hallym University Medical Center-Kangnam
- Enrollment
- 188
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •CRT \= 300 um due to DME or ME secondary to RVO at the time of screening.
- •\- Best corrected visual acuity (BCVA) 20/32\~20/200 at the time of screening .
Exclusion Criteria
- •Excluded if any of the following criteria are met
- •\- If there is a history of intravitreal anti\-VEGF or corticosteroid injection within 3 months of screening.
- •\- In case of receiving systemic anti\-VEGF or corticosteroid treatment within 3 months of screening.
- •\- In the case of receiving panretinal photocoagulation treatment within 3 months of screening.
- •\- In the case of receiving corticosteroid eye drop treatment within 3 months of screening.
- •\- If there is a history of idiopathic or autoimmune uveitis in the trial or the disease is confirmed at the time of screening.
- •\- If you have had intraocular surgery except for simple cataract surgery.
- •\- If there is a history of glaucoma in the trial or the disease is confirmed at the time of screening.
- •\- If there is a history of retinal diseases other than diabetic retinopathy and retinal vein occlusion in the trial, or the disease is confirmed at the time of screening.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Comparison of treatment response to intravitreal injection of triamcinolone, bevacizumab and combined form in patients with Central Retinal Vein Occlusion : A Randomized Clinical Trialthe efficacy of triamcinolone and bevacizumabwas measured in patients with Central Retinal Vein OcclusionBevacizumab,Intravitreal Injections,Retinal Vein Occlusion,TriamcinoloneTCTR20170612005rmia university of medical sciences90
Completed
Phase 4
The study of Intravitreal aflibercept with treat and extend regimen for macular edema with branch retinal vein occlusion (BRVO)Branch retinal vein occlusionJPRN-UMIN000023200Department of Ophthalmology, Akita University50
Unknown
Phase 3
Intravitreal injection versus medical treatment for acute CSREye DiseasesPACTR202204601902304Suez Canal University Hospital45
Active, not recruiting
Phase 1
Comparison of Combined Therapy of Intravitreal Injection of Bevacizumab and Pegaptanib versus Mono-therapy (The MAAM Study) - MAAM-StudyEUCTR2006-001389-18-ATudwig Boltzmann Institute forRetinology and Biomicroscopic Laser Surgery60
Completed
Not Applicable
Combination therapy of intravitreal aflibercept and topical bromfenac for RVOretinal vein occlusionJPRN-UMIN000022988Juntendo Urayasu Hospital40